Nant Capital, LLC
SEC insider (Form 3/4/5 filer). CIK 0001675758. 10% Owner at Panbela Therapeutics, Inc. (PBLA). 1 reported Form 4/5 transaction since Sep 2024; latest on Nov 15, 2024. Located in EL SEGUNDO, CA.
Companies Nant Capital, LLC has filed insider reports for
- Panbela Therapeutics, Inc. (PBLA): 10% Owner
Nant Capital, LLC
CIK: 0001675758
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PBLA
Panbela Therapeutics, Inc.
10% Owner